Physician profile
Lev Belder
NPI 1124139621
$1,848.13
in general payments reported to CMS, 2019-2025
24 companies · $570 in 2025
The $570 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $529 · 2020: $83.23 · 2022: $22.90 · 2023: $311 · 2024: $331 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $339.46 | 2019-2023 | Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $240.30 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $220.08 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $186.58 | 2023-2025 | Aptima, Fluent Fluid Management System, Thinprep 2000 Processor |
| Astellas Pharma US INC | $143.05 | 2023-2025 | Veozah |
| Vertical Pharmaceuticals, LLC | $114.13 | 2019 | |
| Exeltis, USA INC. | $81.72 | 2019-2025 | Slynd |
| Shield Therapeutics INC | $76.75 | 2024 | |
| Daiichi Sankyo INC. | $47.07 | 2019-2020 | |
| Therapeuticsmd, INC. | $44.04 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $43.39 | 2023 | |
| Lupin INC. | $33.70 | 2019-2020 | |
| Pfizer INC. | $33.38 | 2023 | |
| Dexcom, INC. | $33.27 | 2025 | Dexcom G6 Transmitter |
| Mission Pharmacal Company | $30.03 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28.53 | 2019 | |
| Medtronic, INC. | $27.81 | 2023 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $24.27 | 2019 | |
| Boston Scientific Corporation | $22.90 | 2022 | |
| Millicent US INC | $20.12 | 2025 | Intrarosa, Femlyv |
| Organon LLC | $19.22 | 2023 | Nexplanon |
| Amgen INC. | $13.98 | 2025 | Evenity |
| Avion Pharmaceuticals | $12.35 | 2019 | |
| Terumo Medical Corporation | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lev Belder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.